Could syphilis be involved in the patient's symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Could Syphilis Be Involved?

Yes, syphilis should be strongly considered in the differential diagnosis for any patient presenting with unexplained ulcers, rashes, neurologic symptoms, cardiovascular manifestations, or systemic illness, particularly in sexually active individuals. 1

Clinical Presentations That Should Trigger Syphilis Consideration

Primary Syphilis

  • Look for a painless ulcer (chancre) at the site of infection with regional lymphadenopathy, typically appearing 10-90 days after exposure 1, 2
  • Important caveat: The classic "single painless chancre" teaching is outdated—primary syphilitic lesions may be multiple, painful, and atypical, especially in HIV-infected individuals 3, 1
  • The chancre may be missed or absent entirely, particularly in women or with oral/rectal lesions 1
  • Darkfield microscopy or direct fluorescent antibody testing of lesion exudate provides definitive diagnosis during this stage 1, 4

Secondary Syphilis

  • Constitutional symptoms mimicking acute HIV infection: fever, malaise, lymphadenopathy, headache 1
  • Diffuse rash that characteristically involves palms and soles 2, 5
  • Mucocutaneous lesions including condyloma lata (genital/perineal warts) 3, 5
  • Nodular presentations can occur, particularly in HIV-positive patients 6
  • Patchy alopecia, mucous patches in the mouth, and generalized lymphadenopathy 5

Latent Syphilis

  • Positive serologic tests without any clinical manifestations 1
  • Early latent: infection acquired within the preceding 12 months 3
  • Late latent: infection occurred more than 1 year previously 3
  • Latent syphilis of unknown duration: when timing cannot be established, particularly in patients aged 13-35 years with nontreponemal titer ≥32 3

Tertiary Syphilis

  • Occurs in approximately 25% of untreated patients after 3-12 years of latency 1
  • Cardiovascular manifestations: aortitis, aortic aneurysm, aortic regurgitation 3, 1
  • Gummatous lesions: inflammatory lesions of skin, bone, or any organ system 3, 1
  • Late benign syphilis: granulomatous lesions that can involve upper/lower respiratory tracts, mouth, eye, abdominal organs 3

Neurosyphilis (Can Occur at ANY Stage)

  • Critical point: Neurosyphilis can develop at any stage of syphilis, not just late disease 3, 1
  • Neurologic symptoms: meningitis, cranial nerve palsies, stroke, altered mental status 2, 5
  • Ocular involvement: uveitis, optic neuritis, vision changes 3, 1
  • Auditory symptoms: hearing loss, tinnitus 6
  • CSF findings: reactive VDRL in CSF is diagnostic; elevated protein or leukocyte count with negative VDRL is probable neurosyphilis 3

High-Risk Populations Requiring Heightened Suspicion

  • Men who have sex with men (MSM): comprised 32.7% of all males with primary and secondary syphilis in 2023 2
  • People with HIV: increased risk of atypical presentations, multiple lesions, and accelerated disease progression 1, 6
  • Individuals engaging in condomless sex with multiple partners 2
  • Pregnant women: critical to identify due to risk of congenital syphilis and stillbirth 3, 2
  • Persons with history of sexually transmitted infections 3
  • Methamphetamine users and those meeting partners online 3

Diagnostic Approach

Serologic Testing Algorithm

  • Screen with nontreponemal tests (RPR or VDRL) and confirm with treponemal tests (FTA-ABS or TP-PA) 1, 5
  • A fourfold change in nontreponemal titer is clinically significant for monitoring disease activity 1
  • Important consideration: The reverse sequence algorithm (treponemal test first) is increasingly used, but complete endpoint titers must always be reported—laboratories reporting titers as ">1:32" without specifying the actual titer make patient management impossible 3

When to Perform CSF Examination

  • Any neurologic, ocular, or auditory symptoms 3, 1, 6
  • Tertiary syphilis manifestations 7
  • Treatment failure (failure of nontreponemal titers to decline fourfold within 6 months) 6, 7
  • Very high RPR titers in HIV-positive patients 6
  • Late syphilis with clinical manifestations requires CSF analysis to exclude neurosyphilis 3

HIV Testing Mandate

  • All patients diagnosed with syphilis must be tested for HIV 3, 1
  • In high HIV prevalence areas, retest HIV-negative patients with primary syphilis after 3 months 3

Treatment Implications

Standard Treatment

  • Primary/secondary/early latent syphilis: Benzathine penicillin G 2.4 million units IM single dose 1, 8, 2
  • Late latent or unknown duration: Benzathine penicillin G 2.4 million units IM weekly × 3 doses 1
  • Neurosyphilis: Aqueous crystalline penicillin G 18-24 million units IV daily for 10-14 days 1, 6

Penicillin Allergy

  • For early syphilis: Doxycycline 100 mg PO twice daily for 14 days 1, 9, 7
  • For late latent syphilis: Doxycycline 100 mg PO twice daily for 28 days 1, 9
  • For pregnant women and neurosyphilis: Penicillin desensitization is mandatory—no alternatives are acceptable 1, 7

Common Pitfalls to Avoid

  • Don't dismiss syphilis because the lesion is painful or multiple—atypical presentations are increasingly common 3
  • Don't skip CSF examination in patients with neurologic, ocular, or auditory symptoms—neurosyphilis can occur at any stage 3, 6
  • Don't accept incomplete nontreponemal titers from laboratories—endpoint titers are essential for management 3
  • Don't forget that oral lesions may harbor T. pallidum even without visible symptoms—serologic screening is crucial in at-risk patients 3
  • Don't overlook syphilis in pregnant women—up to 40% of fetuses with in-utero exposure are stillborn or die in infancy 2

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Syphilis: test procedures and therapeutic strategies.

Seminars in dermatology, 1990

Research

Diagnosis and management of syphilis.

American family physician, 2003

Guideline

Treatment of Nodular Syphilis in HIV-Positive Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Adult Syphilis: Key Questions to Inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.